TriVascular abdominal stent graft gets FDA approval

7 November 2011 (Last Updated November 7th, 2011 18:30)

The US Food and Drug Administration (FDA) has approved TriVasculars' Ovation abdominal stent graft system to treat abdominal aortic aneurysm.

The US Food and Drug Administration (FDA) has approved TriVasculars' Ovation abdominal stent graft system to treat abdominal aortic aneurysm.

The TriVascular graft system is approved for use in patients with access vessels of less than 7mm in diameter and aortic necks with lengths of at least 7mm and diameters between 15.5mm and 17.4 mm.

The 14F OD low-profile system separates and optimises fixation and seal to treat abdominal aortic aneurysm.

With this approval, the abdominal stent graft system is now available in Europe and US.